What the CEO of the company, Stephan Bansel, said
After the appearance of the Omicron mutation, there has been a lot of talk about it if existing vaccines are able to cover it to a large extent. Moderna, which has developed a vaccine, is reassured about whether it will be able to produce a new vaccine, as the company clarifies that there will be no problem if another vaccine needs to be released, said the company’s CEO, Stefan Bancel. .
Within the next year, the pharmaceutical company wants to start clinical trials because of the mutation which seems to be spreading very fast.
“All that is needed is a little adjustment for Omicron. I do not expect any problems “, Bansel said in an interview published today in the Swiss newspaper TagesAnzeiger.
“This will take another week or two”, clarified Bancell. “It will take a few months before we can prepare 500 million doses after (regulatory) approval. But its potential is much greater today than it was a year ago. “.
If the US Food and Drug Administration and Swissmedic want more studies, it will take at least three months.
“Some authorities are asking for a study, others have not yet decided. In my opinion, it depends a lot on how severe the form of the disease is as it progresses “, completed.
Following delivery and production delays in early 2021, Moderna can now catch up with production targets and deliver orders on time.
In 2021 the company gave 700 to 800 million doses of vaccines and in 2022 it is expected to give even more, as it will give 150 million doses every month.
“We have a new series of vaccines under development”
Mr Bansel then said:
“We have a number of new vaccines under development, for example against the flu or RSV, the ‘respiratory syncytial virus’, which causes a respiratory disease that is fatal for the elderly and young children. We can combine these three mRNA vaccines in one dose and suggest to governments to secure supplies for a certain quantity for many years and then invest in a production unit in this country. “This could give these countries priority in supplies in the event of a new pandemic.”.
See also: Research: How coronavirus affects sperm